NVAC (National Vaccine Advisory Committee). 1997. United States vaccine research: A delicate fabric of public and private collaboration. Pediatrics 100(6):1015-1020.

NVAC. 2003. Strengthening the Supply of Routinely Recommended Vaccines in the United States. Available: http://www.hhs.gov/nvpo/bulletins/nvac-vsr.htm [accessed August 2009].

NVAC. 2009. National Vaccine Advisory Committee (NVAC) February 5-6, 2009, meeting minutes. In National Vaccine Advisory Committee (NVAC) Meeting. Washington, DC: HHS.

NVPO (National Vaccine Program Office). 2009. Summary Report for Comments on the National Vaccine Plan. Available: http://www.hhs.gov/nvpo/vacc_plan/orise_summary_report.pdf [accessed June 2009].

Oliva, A., R. Levin, R. Behrman, and J. Woodcock. 2007. Bioinformatics modernization and the critical path to improved benefit-risk assessment of drugs. Drug Inf J 42:273-279.

Plotkin, S.A. 2005a. Vaccines: Past, present and future. Nat Med 11(4 Suppl):S5-S11.

Plotkin, S.A. 2005b. Why certain vaccines have been delayed or not developed at all. Health Aff 24(3):631-634.

Plotkin, S.A., W.A. Orenstein, and P.A. Offit. 2008. Vaccines, 5th Edition. Philadelphia: Saunders.

Poland, G.A., R.M. Jacobson, and I.G. Ovsyannikova. 2009. Trends affecting the future of vaccine development and delivery: The role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics. Vaccine 27(25-26):3240-3244.

Thalen, M., A. van der Ark, J. van den Ijssel, I. van Straaten, D. Jansen, C. Beuvery, D. Martens, and J. Tramper. 2008. Improving the cellular pertussis vaccine: Increased potency and consistency. Vaccine 26(5):653-663.

Werble, C. 2009a. FDA Sees Boom in Vaccine Applications. Available: http://therpmreport.com/Free/3b15afd4-a05a-4209-bc10-83d5b6c7fa2a.aspx?utm_source=RPMel [accessed May 26, 2009].

Werble, C. 2009b. Vaccine Incentives in the Obama Administration. Available: http://therpmreport.com/Free/2299e06c-0526-4d08-8007-007a9345594d.aspx?utm_source=RPMel [accessed May 26, 2009].

WHO (World Health Organization). 2009. Summary of: WHO Virtual Consultation on the Safety of Adjuvanted Influenza Vaccines. Available: http://www.who.int/vaccine_research/documents/Report_on_consultation_on_adjuvant_safety_2.pdf [accessed November 23, 2009].

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement